Drug Profile
Research programme: immunomodulatory therapeutics - Innate
Alternative Names: KAROSTIM; KIROSTIM; NKStim 2; NKStim 3; NKStim 4Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Innate Pharma
- Class Antibodies; Small molecules
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer; Cutaneous B-cell lymphoma; Haematological malignancies; HIV infections; Inflammation; Malaria; Tuberculosis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in France
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cutaneous-B-cell-lymphoma in France
- 16 Jul 2016 No recent reports of development identified for preclinical development in Haematological-malignancies in France